Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy pens arrive pre-filled with semaglutide, a GLP-1 receptor agonist that slows stomach emptying and reduces appetite signaling in the brain. Each pen typically holds enough medication for multiple weekly injections across a structured titration schedule. PlexusDx offers compounded semaglutide injections starting at $149 per month, allowing patients to access the same active ingredient without Wegovy's brand markup or insurance barriers.

How Many Doses Come in One Wegovy Pen

Wegovy pens are distributed as multi-dose delivery systems rather than single-dose vials. The standard Wegovy starter pack includes four pens designed to deliver the 0.25 mg, 0.5 mg, 1.0 mg, and 1.7 mg doses across the first four weeks of treatment. Each pen contains enough solution for one weekly injection at its designated strength, meaning the 0.25 mg pen holds one dose, the 0.5 mg pen holds one dose, and so on. This design simplifies patient adherence by eliminating the need to calculate or measure doses.

The actual milliliter volume varies by pen strength because semaglutide concentration differs. A 0.25 mg dose occupies less volume than a 1.7 mg dose within the same injection pen format. After the four-week starter phase, maintenance pens arrive as single-dose, pre-filled devices that contain 2.0 mg, 2.4 mg, or another prescribed maintenance strength. Patients inject once weekly until they reach their target dose or achieve weight loss goals.

Understanding the Wegovy Dosing Schedule and Pen Usage

Wegovy follows a 16-week titration protocol that gradually increases semaglutide exposure to allow the body to adapt and minimize gastrointestinal side effects. Week 1 begins with 0.25 mg, week 2 advances to 0.5 mg, week 3 reaches 1.0 mg, and week 4 moves to 1.7 mg. From weeks 5 through 16, patients receive 2.4 mg weekly, which is the standard maintenance dose for most adults. This slow escalation mimics how semaglutide is prescribed in clinical trials, reducing nausea, vomiting, and other adverse effects that occur with rapid dose jumps.

Each Wegovy pen is designed for single use after reconstitution or removal from refrigeration. Once a patient injects the weekly dose, that pen is discarded. The four pens in the starter pack align perfectly with the first month, after which the patient transitions to maintenance pens containing 2.4 mg. Some patients continue on 2.4 mg indefinitely, while others may adjust to 1.7 mg if side effects emerge or to 2.0 mg based on individual response. Understanding this schedule helps patients anticipate supply needs and monthly costs.

Comparing Wegovy Pen Costs to Compounded Semaglutide Alternatives

Wegovy pens carry brand-name pricing that often exceeds $1,300 per month without insurance, reflecting Novo Nordisk's manufacturing, marketing, and distribution expenses. Insurance coverage varies widely; some plans cover Wegovy only for patients with type 2 diabetes plus obesity, while others deny coverage entirely citing insufficient medical necessity. Out-of-pocket costs escalate if insurance denies the claim or if a patient lacks coverage. Wegovy Savings Cards may reduce copays to $250 per month for insured patients, but uninsured individuals face the full retail price.

PlexusDx compounded semaglutide injections begin at $149 per month across all dose levels, with no insurance requirement and no membership fee. Compounded medications are manufactured by licensed 503A compounding pharmacies using pharmaceutical-grade semaglutide powder and injectable solutions, meeting the same quality standards as brand products. PlexusDx services all 50 states and accepts HSA and FSA funds, expanding access for patients who self-insure or carry high-deductible health plans. Your dose may need to go up as your weight loss progresses, but your price won't increase at PlexusDx—the $149 per month rate remains flat whether you're at 0.25 mg or 2.4 mg.

Optimizing Your Semaglutide Journey With Genetic Insights

Individual responses to semaglutide vary based on genetic predispositions affecting GLP-1 receptor function, insulin sensitivity, and appetite regulation. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis that examines key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These genetic markers correlate with how effectively your body responds to GLP-1 therapy, how quickly you lose weight, and which peptide-based treatments may work best for your unique biology. The test maps 14 pathways, 49 peptides, and 150+ genetic insights to guide personalized dosing and compound selection.

Adding the Precision Peptide Genetic Test for $99 after your first month of treatment allows PlexusDx clinicians to refine your protocol based on your genetic profile and early response. Patients with certain GLP1R variants may achieve faster satiety at lower doses, while others may benefit from faster titration to higher maintenance doses. This precision approach eliminates guesswork, optimizes side effect tolerance, and maximizes weight loss outcomes without paying more per month for your medication. Genetic guidance transforms semaglutide from a one-size-fits-all approach into a truly personalized weight loss strategy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many injections are in a single Wegovy pen?

Each Wegovy pen contains one dose of semaglutide at a specific strength (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.0 mg, or 2.4 mg). The starter pack includes four separate pens for weeks 1–4 of titration, then maintenance pens are delivered for ongoing weekly injections. PlexusDx compounded semaglutide provides equivalent dosing flexibility at a flat $149 per month regardless of dose strength.

Can I use part of a Wegovy pen and save the rest for later?

Wegovy pens are designed as single-use, pre-filled injectors and should not be reused or partially injected for later use. Once you remove the needle or inject the dose, the pen must be discarded to maintain sterility and medication stability. Compounded semaglutide from PlexusDx is similarly designed for weekly dosing, ensuring you receive consistent, fresh medication each injection.

Why does PlexusDx compounded semaglutide cost less than Wegovy?

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, eliminating brand-name markups, advertising costs, and intermediary fees associated with Wegovy. At $149 per month flat, compounded semaglutide provides the same active pharmaceutical ingredient without insurance requirements or membership fees, making it accessible to all 50 states via HSA and FSA coverage.

What side effects should I expect when starting a Wegovy pen?

Common side effects during Wegovy titration include nausea, vomiting, constipation, and diarrhea, particularly in the first 2–3 weeks. The gradual dose escalation from 0.25 mg to 2.4 mg over 16 weeks helps your body adapt and reduces severe gastrointestinal upset. PlexusDx clinicians monitor your response and can adjust titration pace or maintenance dose if side effects interfere with daily life.

How does the Precision Peptide Genetic Test improve my semaglutide results?

The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide, appetite signaling, and metabolism. For $99 after your first month of PlexusDx treatment, this test reveals whether you're a fast or slow responder, helping clinicians optimize your dose and compound selection. Genetic insights enable precision dosing, maximize weight loss, and minimize side effects tailored to your unique biology.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves